Comparing Measures of Adherence and Persistence to P2Y12 Inhibitors in Acute Coronary Syndromes

被引：0

作者：

Moon, Jungyeon ^{[1
]}

Ozaki, Aya F. ^{[2
]}

Chong, Alice ^{[3
]}

Sud, Maneesh ^{[4
]}

Fang, Jiming ^{[3
]}

Austin, Peter C. ^{[3
]}

Ko, Dennis T. ^{[3
,4
,5
]}

Jackevicius, Cynthia A. ^{[1
,3
,4
,6
]}

机构：

[1] Western Univ Hlth Sci, Coll Pharm, Pomona, CA 91766 USA

[2] Univ Calif Irvine, Sch Pharm & Pharmaceut Sci, Irvine, CA USA

[3] ICES, Toronto, ON, Canada

[4] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada

[5] Sunnybrook Hlth Sci Ctr, Schulich Heart Ctr, Toronto, ON, Canada

[6] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2024年 / 226卷

基金：

加拿大健康研究院;

关键词：

clopidogrel; ticagrelor; adherence; persistence; acute coronary syndromes; P2Y12; inhibitors;

D O I：

10.1016/j.amjcard.2024.04.047

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：134 / 136

页数：3

共 50 条

[41] New P2Y12 Inhibitors
Cattaneo, Marco
CIRCULATION, 2010, 121 (01) : 171 - 179
[42] P2Y12 inhibitors for the neurointerventionalist
Borchert, Robin J.
Simonato, Davide
Hickman, Charlotte
Fuschi, Maurizio
Thibault, Lucie
Henkes, Hans
Fiorella, David
Tan, Benjamin Y. Q.
Yeo, Leonard L. L.
Makalanda, Hegoda L.
Wong, Ken
Bhogal, Pervinder
INTERVENTIONAL NEURORADIOLOGY, 2022, 28 (01) : 92 - 103
[43] Introduction -: Emerging issues and new pharmacologic options for P2Y12 inhibition in acute coronary syndromes
Wallentin, Lars
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2008, 10 (0D) : D2 - D2
[44] P2Y12 Inhibitors in Acute Coronary Syndromes: A Real-World, Community-Based Comparison of Ischemic and Bleeding Outcomes
Sachdeva, Amit
Mutyala, Ratnabhushan
Mantri, Neha
Zhu, Shiyun
McNulty, Edward
Solomon, Matthew
JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2023, 2023
[45] New P2Y12 inhibitors for the treatment of coronary artery disease
Gurbel, P. A.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 4 - 5
[46] Safety and efficacy of different P2Y12 inhibitors in patients with acute coronary syndromes stratified by the PRAISE risk score: a multicentre study
Patti, Giuseppe
D'Ascenzo, Fabrizio
De Filippo, Ovidio
Bruno, Francesco
Leonardi, Sergio
Chieffo, Alaide
Iannaccone, Mario
Liebetrau, Christoph
Manzano-Fernandez, Sergio
Gallone, Guglielmo
Omede, Pierluigi
Cerrato, Enrico
Kinnaird, Tim
Conrotto, Federico
Piroli, Francesco
Henriques, Jose Paulo Simao
Wanha, Wojciech
Elia, Edoardo
Dominguez-Rodriguez, Alberto
Raposeiras-Roubin, Sergio
Abu-Assi, Emad
De Ferrari, Gaetano Maria
EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2022, 8 (08) : 881 - 891
[47] Switching of platelet P2Y12 receptor inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Review of the literature and practical considerations
De Luca, Leonardo
Capranzano, Piera
Patti, Giuseppe
Parodi, Guido
AMERICAN HEART JOURNAL, 2016, 176 : 44 - 52
[48] De-escalation of P2Y12 Inhibitor Use After Percutaneous Coronary Intervention and Acute Coronary Syndromes
Barry, Quinton
Fu, Angel
Boudreau, Rene
Chow, Alyssa
Clifford, Cole
Simard, Trevor
Chong, Aun Yeong
Dick, Alexander
Froeschl, Michael
Glover, Christopher
Hibbert, Benjamin
Labinaz, Marino
Le May, Michel
Russo, Juan
So, Derek
CJC OPEN, 2021, 3 (09) : 1091 - 1099
[49] P2Y12 Inhibitors in Chronic Coronary Syndromes Undergoing Elective PCI Any Niche for Potent Agents?
Ferreiro, Jose Luis
JACC-CARDIOVASCULAR INTERVENTIONS, 2024, 17 (03) : 371 - 373
[50] Antiplatelet Therapy n ACS Patients: Comparing Appropriate P2Y12 Inhibition by Clopidogrel to the Use of New P2Y12 Inhibitors
Ristorto, Jessica
Messas, Nathan
Marchandot, Benjamin
Kibler, Marion
Hess, Sebastien
Meyer, Nicolas
Schaeffer, Michael
Tuzin, Nicolas
Ohlmann, Patrick
Jesel, Laurence
Morel, Olivier
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2018, 25 (08) : 674 - 689

← 1 2 3 4 5 →